Close Menu
July 15, 2020
Sponsored by
LGC SeraCare Life Sciences

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Genome Webinar

Chief Scientific Officer, Foundation Medicine

Global Head of Medical Affairs,
Clinical NGS and Oncology Division, Thermo Fisher Scientific

VP Translational Science, Oncology, AstraZeneca

President & Chief Technology Officer,  Genosity

Vice President, Assay Development, Illumina

Chief Scientific Officer, LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer. However, only a minority of patients with terminal cancer have durable response with approved immuno-oncology treatments.

This webinar will feature a panel of experts in the field who will provide key insights into the current advances in cancer diagnostics and immunotherapy, as well as challenges facing the discipline.

The panelists bring a wealth of expertise and differing viewpoints in clinical laboratory practice, cancer research, translational sciences, and immuno-oncology diagnostics and therapeutics at the molecular and cellular levels important to the care and management of cancer patients and treatment outcomes. Each speaker will have an opportunity to share their perspectives on this topic, which will be moderated by Dr. Russell Garlick, Chief Scientific Officer at LGC SeraCare. The presentation will be followed by a live Q&A to allow attendees to address the experts directly.

Sponsored by